Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 2, 1998

View Archived Issues

Diane-35 now available in Canada for treatment of acne

U.S. patent issued for Maxim's MaxVax technology

LIPID study establishes efficacy of pravastatin in patients with lower cholesterol levels

Vical provides clinical update of Leuvectin in treatment of prostate cancer

Mechanism-of-action studies of nifekalant described

Improved antibacterial efficacy observed with OPC-20011

Microbix and Gensia Sicor terminate licensing agreement

Sonus and Daiichi terminate licensing agreement

AMBI seeks partners to develop oral nisin for H. pylori eradication

FDA approves new indications, dosing regimens for Vantin

Health Canada approves lamivudine for treatment of chronic HBV

CPMP issues positive opinion for E.U. approval of Zenapax

Pfizer announces further product launches for novel quinolone

Preclinical study results indicate feasibility of long-term administration of antihypertensive drug

Inhibitors of neovascularization (angiogenesis) patented by JT

Taisho discloses new antitumor series

Gene therapies for neuromuscular diseases pursued by Transgene and AFM

U.K. approval for new controlled-release nifedipine based on TIMERx technology

Albuterol delivered by novel MSI system enters clinical evaluation

Lead SelCID compound poised to enter phase II clinical trials for Crohn's disease

Novel injectable drug delivery technology in-licensed by Medi-Ject

Isis sublicenses technology for designing improved antisense drugs

Additional dose of 5G1.1-SC for phase IIb CPB study identified in phase I trial

Clinical anti-HIV activity of FTC correlated with intracellular levels of triphosphate

Hydroxyurea-containing salvage regimens for advanced-stage HIV infection

Lack of cardiotoxicity of SM-5887 confirmed in dogs

Advisory committee recommends approval of Celebrex for arthritis and further discussions for pain

Comparison of LT and TxA2 antagonists in asthmatic patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...